Beijing Tiantan Biological Products Corp Ltd. Stock Analysis 600161.SS

Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production and sale of biological products. The company is headquartered in Beijing, Beijing and currently employs 5,205 full-time employees. The firm's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human immunoglobulin, human rabies immunoglobulin, human hepatitis B immunoglobulin, human histamine immunoglobulin, human prothrombin complex and others. The firm's products are mainly used to treat shock caused by blood loss, trauma and burns, treat primary immunoglobulin G deficiency, neonatal sepsis, infant bronchiolitis, prevent and treat tetanus and others. The firm mainly operates its businesses in the domestic and overseas markets.